Proton pump inhibitors and pain

Pain Physician

Volumn 12, Issue 6, 2009, Pages 1013-1023

  Smith, Howard S ^a   Dhingra, Reena ^a   Ryckewaert, Lori ^a   Bonner, Dave ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b Adirondack Area Network   (United States)

Author keywords

Iron absorption; Iron deficiency; Pain; Proton pump inhibitor (PPI); Restless Leg Syndrome (RLS); Restless Leg Syndrome Associated Pain (RLSAP)

Indexed keywords

IRON DEXTRAN; OMEPRAZOLE; PROTON PUMP INHIBITOR;

DRUG MECHANISM; DUODENUM PH; FERRITIN BLOOD LEVEL; HUMAN; IRON ABSORPTION; IRON DEFICIENCY; PAIN; PATHOGENESIS; RESTLESS LEGS SYNDROME; RESTLESS LEGS SYNDROME ASSOCIATED PAIN; REVIEW; SENSORIMOTOR FUNCTION; SIDE EFFECT; TIBIA;

ANALGESICS, OPIOID; ANIMALS; HUMANS; IRON; NEURALGIA; PROTON PUMP INHIBITORS; RESTLESS LEGS SYNDROME;

EID: 76549099632     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (93)

1. O'Keeffe ST. Restless legs syndrome. A review. Arch Intern Med 1996; 156:243-248.
2. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995; 10:634-642.
3. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C; International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4:121-132.
4. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J; International Restless Legs Syndrome Study Group. Restless legs syndrome: Diagnostic criteria, special considerations and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4:101-119.
5. Hening WA, Allen RP, Washburn M, Lesage S, Earley CJ. Validation of the Hopkins telephone diagnostic interview for restless legs syndrome. Sleep Med 2008; 3:283-289.
6. Hening W, Allen R, Washburn M, Lesage S, Earley C. Mimics of the restless legs syndrome can often satisfy the standard diagnostic critera (abstr.). Sleep 2004; 27:A297.
7. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000; 160:2137-2141.
8. Montplaisir, J, Boucher, S, Poirier, G, Lavigne G, Lapierre O, Lespérance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria. Mov Disord 1997; 12:61-65.
9. Oertel WH, Trenkwalder C, Zucconi M, Benes H, Borreguero DG, Bassetti C, Partinen M, Ferini-Strambi L, Stiasny-Kolster K. State of the art in restless legs syndrome therapy: Practice recommendations for treating restless legs syndrome. Movement Disorders 2007; 22:S466-S475.
10. Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, Costa J, Stiasny-Kolster K, Sampaio C. Treatment of restless legs syndrome: An evidence-based review and implications for clinical practice. Mov Disord 2008; 23:2267-2302.
11. Winkelmann J, Wetter TC, Collado-Seidel V, Gasser T, Dichgans M, Yassouridis A, Trenkwalder C. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 2000; 23:597-602.
12. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep 1999; 22:970-999.
13. Stiasny-Kolster K, Magerl W, Oertel WH, Möller JC, Treede RD. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain 2004; 127:773-782.
14. Paulus W, Dowling P, Rijsman R, Stiasny-Kolster K, Trenkwalder C, de Weerd A. Pathophysiological concepts of restless legs syndrome. Mov Disord 2007; 22:1451-1456.
15. Polydefkis M, Allen RP, Hauer P, Earley CJ, Griffin JW, McArthur JC. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology 2000; 55:1115-1121.
16. Schattschneider J, Bode A, Wasner G, Binder A, Deuschl G, Baron R. Idiopathic restless legs syndrome: Abnormalities in central somatosensory processing. J Neurol 2004; 251: 977-982.
17. Gemignani F, Brindani F, Negrotti A, Vitetta F, Alfieri S, Marbini A. Restless legs syndrome and polyneuropathy. Mov Disord 2006; 21: 1254-1257.
18. Gemignani F, Bridani F, Vitetta F, Marbini A. Restless leg syndrome and pain neuropathy - retrospective study. A role for nociceptive deafferentation? Pain Med In Press.
19. Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: Irritable nociceptors and deafferentation. Neurobiol Dis 1998; 5:209-227.
20. Baumgärtner U, Magerl W, Klein T, Hopf HC, Treede RD. Neurogenic hyperalgesia versus painful hypoalgesia: Two distinct mechanisms of neuropathic pain. Pain 2002; 96:141-151.
21. Allen RP, Earley CJ. Validation of the Johns Hopkins restless legs severity scale. Sleep Med 2001; 2:239-242.
22. Cook JD, Skikne BS, Lynch SR, Reusser ME. Estimates of iron sufficiency in the US population. Blood 1986; 68:726-731.
23. McCance RA, Widdowson EM. The absorption and excretion of iron following oral and intravenous administration. J Phys 1938; 94:148-154.
24. Hallberg L. Bioavailability of dietary iron in man. Annu Rev Nutr 1981; 1:123-127.
25. Bezwoda W, Charlton R, Bothwell T, Torrance J, Mayet F. The importance of gastric hydrochloric acid in the absorption of nonheme food iron. J Lab Clin Med 1978; 92:108-116.
26. Lind T, Rydberg L, Kylebäck A, Jonsson A, Andersson T, Hasslegren G, Holmberg J, Röhss K. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastrooesophageal reflux disease. Aliment Pharmacol Ther 2000; 14:861-867.
27. Champagne ET. Low gastric hydrochloric acid secretion and mineral bioavailability. Adv Exp Med Biol 1989; 249:173-184.
28. Archambault AP, Rovelstad RA, Carlson HC. In situ pH of duodenal bulb contents in normal and duodenal ulcer subjects. Gastroenterology 1967; 52:940-947.
29. Schade SG, Cohen RJ, Conrad ME. Effect of hydrochloric acid on iron absorption. N Engl J Med 1968; 279:672-674.
30. Miret S, Simpson RJ, McKie AT. Physiology and molecular biology of dietary iron absorption. Annu Rev Nutr 2003; 23:283-301.
31. Zoller H, Koch RO, Theurl T, Obrist P, Pietrangelo A, Montosi G, Haile DJ, Vogel W, Weiss G. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 2001; 120:1412-1419.
32. Griffiths WJ, Sly WS, Cox TM. Intestinal iron uptake determined by divalent metal transporter is enhanced in HFE-deficient mice with hemochromatosis. Gastroenterology 2001; 120:1420-1429.
33. Stuart KA, Anderson GJ, Frazer DM, Powell LW, McCullen M, Fletcher LM, Crawford DH. Duodenal expression of iron transport molecules in untreated haemochromatosis subjects. Gut 2003; 52:953-959.
34. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306:2090-2093.
35. Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, Subramaniam VN, Powell LW, Anderson GJ, Ramm GA. Disrupted hepcidin regulation in HFE-related haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 2003; 361:669-673.
36. Gehrke SG, Kulaksiz H, Herrmann T, Riedel HD, Bents K, Veltkamp C, Stremmel W. Expression of hepcidin in hereditary hemochromatosis: Evidence for a regulation in response to serum trans-ferrin saturation and non-transferrinbound iron. Blood 2003; 102:371-376.
37. Muir A, Hopfer U. Regional specificity of iron uptake by small intestinal brush-boarder membranes from normal and iron deficient mice. Gastrointestinal and Liver Pathology 1985; 11:6376-6379.
38. Koop H, Bachem M G. Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy. J Clin Gastroenterol 1992; 14:288-292.
39. Stewart C, Termanini V, Sutliff VE, Serrano J, Yu F, Gibril F, Kensen R.T. Iron absorption in patients with Zollinger-Ellison Syndrome treated with long-term gastric acid antisecretory therapy. Ailment Pharmacol Ther 1998; 12:83-98.
40. Hutchinson C, Giessler C, Powell J, Bomford A. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut 2007; 56:1291-1295.
41. Lynch SR, Skikne BS, Cook JD. Food iron absorption in idiopathic hemochromatosis. Blood 1989; 74:2187-2193.
42. Powell LW, Campbell CB, Wilson E. Intestinal mucosal uptake of iron and iron retention in idiopathic haemochromatosis as evidence for a mucosal abnormality. Gut 1970; 11:727-731.
43. Marx JJM. Mucosal uptake, mucosal transfer and retention of iron, measured by whole-body counting. Scand J Haematol 1979; 23:293-302.
44. Turnbull A, Cleton F, Finch CA. Iron absorption. IV. The absorption of hemoglobin iron. J Clin Invest 1962; 41:1897-1907.
45. Pietrangelo A. Hereditary hemochromatosis: A new look at an old disease. N Eng J Med 2004; 350:2383-2397.
46. Dooley J, Worwood M. Guidelines on diagnosis and therapy: Genetic haemochromatosis. British Committee for Standards in Haematology 2000. Abingdon, Oxford, Darwin Medical Communications Ltd. www.bcshguidelines.com/.
47. Ekbom KA. Restless legs. Ivar Haeggströms; Stockholm, 1945.
48. Nordlander NB. Restless Legs. Br J Phys Med 1954; 17:160 -162.
49. Nordlander NB. Therapy in restless legs. Acta Med Scand 1953; 145:453-457.
50. Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 1999; 52:932-937.
51. Akyol A, Kiylioglu N, Kadikoylu G, Bolaman AZ, Ozgel N. Iron deficiency anemia and restless legs syndrome: Is there an electrophysiological abnormality? Clin Neurol Neurosurg 2003; 106:23-27.
52. Earley CJ, Allen RP, Beard JL, Connor JR. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res 2000; 62:623-628.
53. Earley CJ, Connor JR, Beard JL, Alecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferring in restless legs syndrome. Neurology 2000; 54:1698-1700.
54. Sloand JA, Shelly MA, Feigin A, Bernstein P, Monk RD. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis 2004; 43:663- 670.
55. Manconi M, Govoni V, De Vito A, Economou NT, Cesnik E, Mollica G, Granieri E. Pregnancy as a risk factor for restless legs syndrome. Sleep Med 2004; 5:305-308.
56. O'Keeffe ST, Noel J, Lavan JN. Restless legs syndrome in the elderly. Postgrad Med J 1993; 69:701-703.
57. Ekbom KA. Restless legs syndrome after partial gastrectomy. Acute Neurol Scand 1966; 42:79-89.
58. Happe S, Tings T, Schettler V, Canelo M, Paulus W, Trenkwalder C. Low-density lipoprotein apheresis and restless legs syndrome. Sleep 2003; 26:A335-A336.
59. Tings T, Schettler V, Canelo M, Paulus W, Trenkwalder C. Impact of regular LDL apheresis on the development of restless legs syndrome. Mov Disord 2004; 19:1072-1075.
60. Hogl B, Kiechl S, Willeit J, Saletu M, Frauscher B, Seppi K, Müller J, Rungger G, Gasperi A, Wenning G, Poewe W. Restless legs syndrome: A community-based study of prevalence, severity, and risk factors. Neurology 2005; 64:1920-1924.
61. Berger K, von Eckardstein A, Trenkwalder C, Rothdach A, Junker R, Weiland SK. Iron metabolism and the risk of restless legs syndrome in an elderly general population - the MEMO-Study. J Neurol 2002; 249:1195-1199.
62. Alvarez-Ossorio L, Kirchner H, Kluter H, Schlenke P. Low ferritin levels indicate the need for iron supplementation: Strategy to minimize iron-depletion in regular blood donors. Transfus Med 2000; 10:107-112.
63. Guyatt GH, Patterson C, Ali M, Singer J, Levine M, Turpie I, Meyer R. Diagnosis of iron-deficiency anemia in the elderly. Am J Med 1990; 88:205-209.
64. Silber MH, Ehrenberg BL, Allen RP, Buchfuhrer MJ, Earley CJ, Hening WA, Rye DB; Medical Advisory Board of the Restless Legs Syndrome Foundation. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 2004; 79:916-922.
65. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994; 23:200-203.
66. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep 1998; 21:371-377.
67. Wang Y, Mysliviec V, Fischer C, Dehaan P, Owshalipur D, Mysliviec A. Efficacy of iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo controlled study. In: Association of Professional Sleep Societies. Sleep. Salt Lake City, Utah, USA, 2006. p A273.
68. Earley CJ, Barker PB, Horska A, Allen RP. MRI-determined regional brain iron concentrations in early- and late-on-set restless legs syndrome. Sleep Med 2006; 7:459-461.
69. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001; 56:263-265.
70. Schmidauer C, Sojer M, Seppi K, Stockner H, Högl B, Bidermann B, Brandauer E, Peralta CM, Wenning GK, Poewe W. Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 2005; 58:630-634.
71. Connor JR, Boyer PJ, Menzies SL, Dellinger B, Allen RP, Earley CJ. Neuro pathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003; 61:304- 309.
72. Connor JR, Wang XS, Patton SM, Menzies SL, Tronocoso JC, Earley CJ, Allen RP. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 2004; 62:1563-1567.
73. Earley CJ, Heckler D, Allen RP. IV Iron treatment for the restless legs syndrome (RLS). Sleep 2001; 24:A359.
74. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005;14:43-47.
75. Zhao H, Zhu W, Pan T, Xie W, Zhang A, Ondo WG, Le W. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. J Neurosco Res 2007; 85:1065-1076.
76. Cortese S, Lecendreux M, Bernardina BD, Mouren MC, Sbarbati A, Konofal E. Attention-deficit/hyperactivity disorder, Tourette's syndrome, and restless legs syndrome: The iron hypothesis. Med Hypotheses 2008; 70:1128-1132.
77. Lespérance P, Djerroud N, Diaz Anzaldua A, Rouleau GA, Chouinard S, Richer F, Montréal Tourette Study Group. Restless legs in Tourette syndrome. Mov Disord 2004; 19:1084-1087.
78. Konofal E, Cortese S, Marchand M, Mouren MC, Arnulf I, Lecendreux M. Impact of restless legs syndrome and iron deficiency on attention-deficit/ hyperactivity disorder in children. Sleep Med 2007; 8:711-715.
79. Oner P, Dirik EB, Taner Y, Caykoylu A, Anlar O. Association between low serum ferritin and restless legs syndrome in patients with attention deficit hyperactivity disorder. Tohoku J Exp Med 2007; 213:269-276.
80. Earley CJ, Heckler D, Allen RP. The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 2004; 5:231-235.
81. Earley C, Heckler D, Allen RD. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome. Sleep Med 2005; 6:301-305.
82. Sharma VR, Brannon MA, Carloss EA. Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. South Med J 2004; 97; 887-889.
83. Wang J, O'Reilly B, Venkataraman R, Mysliwiec V, Mysliwiec A. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study. Sleep Med 2009 In Press.
84. Earley CJ. The importance of oral iron therapy in restless legs syndrome. Sleep Med 2009, In Press.
85. Walters AS, Wagner ML, Hening WA, Grasing K, Mills R, Chokroverty S Kavey N. Successful treatment of the idiopathic restless legs syndrome in a randomized double blind trial of oxycodone versus placebo. Sleep 1993; 16:327-332.
86. Walters AS, Winkelmann J, Trenkwalder C, Fry JM, Kataria V,Wagner M, Sharma R, Hening W, Li L. Longterm follow-up on restless legs syndrome patients treated with opioids. Mov Disord 2001; 16:1105-1109.
87. Von Spiczak S, Whone AL, Hammers A, Asselin MC, Turkheimer F, Tings T, Happe S, Paulus W, Trenkwalder C, Brooks DJ. The role of opioids in restless legs syndrome: An (11C) diprenorphine PET study. Brain 2005; 128:906-917.
88. Hening W, Walters A, Kavey N, Gidro-Frank S, Cote L, Fahn S. Dyskinesia while awake and periodic movements of sleep in restless legs syndrome: treatment with opioids. Neurology 1986; 36:1363-1366.
89. Walters A, Hening W, Cote L, Fahn S. Dominantly inherited restless legs with myoclonus and periodic movements of sleep: A syndrome related to the endogenous opiates? Adv Neurol 1986; 43:309-319.
90. Walters AS, Ondo WG, Zhu W, Le W. Does the endogenous opiate system play a role in the restless legs syndrome?: A pilot post-mortem study. J Neurolog Sci 2009; 279:62-65.
91. Connor JR. Pathophysiology of restless legs syndrome: Evidence for iron involvement. Curr Neurol Neurosci Rep 2008; 8:162-166.
92. Yehuda S, Youdim MB. Brain iron: A lesson from animal models. Am J Clin Nutrn 1989; 50:618-625.
93. Pearson VE, Gamaldo CE, Allen RP, Lesage S, Hening WA, Earley CJ. Medication use in patients with restless legs syndrome compared with a control population. Eur J Neuro 2008; 15:16-21.